PEDIATRICS Vol. 83 No. 5 May 1989, pp. 674-678
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilman, J. T.
Right arrow Articles by Ransom, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilman, J. T.
Right arrow Articles by Ransom, J. L.

Rapid Sequential Phenobarbital Treatment of Neonatal Seizures

Jamie T. Gilman PharmD1, Peter Gal PharmD1, Michael S. Duchowny MD1, Richard L. Weaver MD1, and J. Lawrence Ransom MD1

1 The Comprehensive Epilepsy Center, Pharmacokinetics Laboratory, Miami Children's Hospital, Miami, and the Greensboro Area Health Education Center and Department of Neonatal Medicine, Moses H. Cone Memorial Hospital, Greensboro, North Carolina

The optimal serum concentration of phenobarbital in newborns and its safety at high doses are not well established. The dose response relationship of rapid sequential phenobarbital loading in the newborn was examined and the efficacy of high-dose monotherapy was compared with the addition of a second anticonvulsant for persistent seizure activity. A single loading dose of phenobarbital 15 to 20 mg/kg was initially administered to 120 newborns. Nonresponders received sequential bolus doses of 5 to 10 mg/kg until seizures ceased or a serum concentration of 40µg/mL was obtained. Infants with refractory seizures received additional phenobarbital to a maximum serum concentration of 100 µg/mL. The seizures of 48 babies (40%) were controlled after initial loading and 37 of the remaining 72 subjects (51%) responded at serum concentrations of as great as 40 µg/ mL. The seizures of only seven subjects were controlled at greater concentrations. A second anticonvulsant controlled seizures in 13 of the 28 subjects (46%) whose seizures were refractory to phenobarbital. A gestational age of less than 32 weeks was associated with a significantly better response to phenobarbital. Serum phenobarbital concentrations greater than 50 µg/mL produced only occasional feeding difficulty and sedation. It was concluded that sequentially administered IV phenobarbital controls seizures in both term and preterm newborns (77%). This therapeutic effect is dose dependent but plateaus at a serum concentration of 40 µg/mL. At greater serum concentrations, unresponsive patients should receive a second antiepileptic agent.

Key Words: phenobarbital • neonatal seizures • phenytoin • lorazepam

Submitted on May 2, 1988
Accepted on June 27, 1988




This article has been cited by other articles:


Home page
 NeoReviewsHome page
J. J. Riviello Jr
Pharmacology Review: Drug Therapy for Neonatal Seizures: Part 1
NeoReviews, May 1, 2004; 5(5): e215 - e220.
[Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
G B Boylan, J M Rennie, R M Pressler, G Wilson, M Morton, and C D Binnie
Phenobarbitone, neonatal seizures, and video-EEG
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2002; 86(3): F165 - F170.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
S. Sulzbacher, J. R. Farwell, N. Temkin, A. S. Lu, and D. G. Hirtz
Late Cognitive Effects of Early Treatment with Phenobarbital
Clinical Pediatrics, July 1, 1999; 38(7): 387 - 394.
[Abstract] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
D. Evans and M. Levene
Neonatal seizures
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 1998; 78(1): 70F - 75.
[Full Text]

Home page
 J Child NeurolHome page
J. Maytal, G. P. Novak, and K. C. King
Lorazepam in the Treatment of Refractory Neonatal Seizures
J Child Neurol, October 1, 1991; 6(4): 319 - 323.
[Abstract] [PDF]